Trgovina Biodesix, Inc. - BDSX CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.0462 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.030779% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | -0.013666% | ||||||||
| Čas nočne pristojbine | 22:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ključni statistični podatki
| Predhodno. Zapri* | 1.9768 |
| Odpri* | 1.9968 |
| Enoletna sprememba* | -45.89% |
| Dnevni razpon* | 1.857 - 1.9968 |
| Razpon 52 wk | 0.96-3.87 |
| Povprečni obseg (10 dni) | 132.18K |
| Povprečni obseg (3 meseci) | 4.08M |
| Tržna kapitalizacija | 144.81M |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 71.69M |
| Prihodki | 35.83M |
| EPS | -1.73 |
| Dividenda (donosnost v %) | N/A |
| Beta | -100.00K |
| Datum naslednjega zaslužka | Mar 13, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Feb 7, 2023 | 1.9069 | -0.0300 | -1.55% | 1.9369 | 1.9968 | 1.8370 |
| Feb 6, 2023 | 1.9768 | 0.0499 | 2.59% | 1.9269 | 2.0168 | 1.9269 |
| Feb 3, 2023 | 1.9169 | -0.1498 | -7.25% | 2.0667 | 2.1067 | 1.7871 |
| Feb 2, 2023 | 2.1466 | -0.2296 | -9.66% | 2.3762 | 2.4262 | 2.1266 |
| Feb 1, 2023 | 2.3263 | -0.1099 | -4.51% | 2.4362 | 2.4362 | 2.2663 |
| Jan 31, 2023 | 2.3862 | -0.0399 | -1.64% | 2.4261 | 2.5061 | 2.3262 |
| Jan 30, 2023 | 2.3862 | -0.0299 | -1.24% | 2.4161 | 2.4561 | 2.2663 |
| Jan 27, 2023 | 2.4661 | 0.1598 | 6.93% | 2.3063 | 2.4961 | 2.2963 |
| Jan 26, 2023 | 2.3163 | -0.0200 | -0.86% | 2.3363 | 2.4961 | 2.2763 |
| Jan 25, 2023 | 2.3563 | -0.0399 | -1.67% | 2.3962 | 2.4561 | 2.2663 |
| Jan 24, 2023 | 2.3463 | 0.0200 | 0.86% | 2.3263 | 2.3962 | 2.3063 |
| Jan 23, 2023 | 2.3263 | 0.0100 | 0.43% | 2.3163 | 2.3962 | 2.2264 |
| Jan 20, 2023 | 2.3862 | 0.1498 | 6.70% | 2.2364 | 2.3862 | 2.1965 |
| Jan 19, 2023 | 2.2165 | -0.0199 | -0.89% | 2.2364 | 2.2365 | 2.1765 |
| Jan 18, 2023 | 2.2464 | -0.1697 | -7.02% | 2.4161 | 2.4162 | 2.1665 |
| Jan 17, 2023 | 2.3862 | -0.0799 | -3.24% | 2.4661 | 2.4861 | 2.3462 |
| Jan 13, 2023 | 2.4761 | 0.1498 | 6.44% | 2.3263 | 2.4861 | 2.2464 |
| Jan 12, 2023 | 2.4661 | 0.0599 | 2.49% | 2.4062 | 2.4661 | 2.3262 |
| Jan 11, 2023 | 2.3862 | -0.0100 | -0.42% | 2.3962 | 2.4561 | 2.2464 |
| Jan 10, 2023 | 2.3563 | -0.0599 | -2.48% | 2.4162 | 2.4162 | 2.1466 |
Biodesix, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Skupni prihodki | 20.432 | 24.552 | 45.557 | 54.506 |
| Prihodki | 20.432 | 24.552 | 45.557 | 54.506 |
| Celotni stroški prihodkov | 4.406 | 6.074 | 21.998 | 30.518 |
| Bruto dobiček | 16.026 | 18.478 | 23.559 | 23.988 |
| Celotni odhodki iz poslovanja | 44.095 | 51.293 | 68.491 | 93.148 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 25.899 | 30.637 | 32.328 | 47.958 |
| Raziskave in razvoj | 8.188 | 10.468 | 10.818 | 12.789 |
| Nenavadni odhodki (prihodki) | 5.602 | 4.114 | 0.818 | -0.676 |
| Prihodki iz poslovanja | -23.663 | -26.741 | -22.934 | -38.642 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -2.892 | -2.953 | -7.586 | -4.508 |
| Drugo, neto | 0.389 | -1.032 | -0.83 | -0.009 |
| Čisti dobiček pred obdavčitvijo | -26.166 | -30.726 | -31.35 | -43.159 |
| Čisti dobiček po davkih | -26.166 | -30.726 | -31.35 | -43.159 |
| Čisti dobiček pred dodatnimi postavkami | -26.166 | -30.726 | -31.35 | -43.159 |
| Čisti dobiček | -26.166 | -30.726 | -31.35 | -43.159 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -26.166 | -30.726 | -31.35 | -43.159 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -26.166 | -30.726 | -31.35 | -43.159 |
| Popravljen čisti dobiček | -26.166 | -30.726 | -31.35 | -43.159 |
| Popravljene ponderirane povprečne delnice | 26.2541 | 26.2541 | 26.5615 | 27.365 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.99665 | -1.17033 | -1.18028 | -1.57716 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.78327 | -1.01363 | -1.14948 | -1.60186 |
| Depreciation / Amortization | 2.529 | 2.559 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Skupni prihodki | 28.866 | 11.885 | 6.531 | 7.224 | 6.548 |
| Prihodki | 28.866 | 11.885 | 6.531 | 7.224 | 6.548 |
| Celotni stroški prihodkov | 18.218 | 7.085 | 2.722 | 2.493 | 3.235 |
| Bruto dobiček | 10.648 | 4.8 | 3.809 | 4.731 | 3.313 |
| Celotni odhodki iz poslovanja | 35.177 | 22.472 | 16.499 | 19 | 21.009 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 11.927 | 11.425 | 13.607 | 13.558 | 14.487 |
| Raziskave in razvoj | 3.321 | 3.323 | 3.293 | 2.852 | 3.206 |
| Nenavadni odhodki (prihodki) | 1.711 | 0.639 | -3.123 | 0.097 | 0.081 |
| Prihodki iz poslovanja | -6.311 | -10.587 | -9.968 | -11.776 | -14.461 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -0.651 | -0.815 | -1.546 | -1.496 | -1.137 |
| Drugo, neto | 0.001 | 0 | 0 | -0.01 | 0.012 |
| Čisti dobiček pred obdavčitvijo | -6.961 | -11.402 | -11.514 | -13.282 | -15.586 |
| Čisti dobiček po davkih | -6.961 | -11.402 | -11.514 | -13.282 | -15.586 |
| Čisti dobiček pred dodatnimi postavkami | -6.961 | -11.402 | -11.514 | -13.282 | -15.586 |
| Čisti dobiček | -6.961 | -11.402 | -11.514 | -13.282 | -15.586 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -6.961 | -11.402 | -11.514 | -13.282 | -15.586 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -6.961 | -11.402 | -11.514 | -13.282 | -15.586 |
| Popravljen čisti dobiček | -6.961 | -11.402 | -11.514 | -13.282 | -15.586 |
| Popravljene ponderirane povprečne delnice | 26.604 | 27.73 | 28.051 | 27.059 | 31.07 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.26165 | -0.41118 | -0.41047 | -0.49085 | -0.50164 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.19734 | -0.38814 | -0.5218 | -0.48727 | -0.49903 |
- Letni
- Četrtletno
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 9.913 | 12.7 | 86.14 | 43.613 |
| Denarna sredstva in kratkoročne naložbe | 5.914 | 5.286 | 62.126 | 32.712 |
| Denarna sredstva in ustrezniki | 5.914 | 5.286 | 62.126 | 32.712 |
| Celotne terjatve, neto | 1.892 | 5.292 | 15.304 | 3.656 |
| Accounts Receivable - Trade, Net | 1.892 | 5.292 | 15.304 | 3.656 |
| Other Current Assets, Total | 2.107 | 2.122 | 8.71 | 7.245 |
| Total Assets | 39.057 | 41.633 | 121.07 | 76.097 |
| Property/Plant/Equipment, Total - Net | 1.388 | 2.12 | 3.178 | 4.179 |
| Property/Plant/Equipment, Total - Gross | 6.956 | 8.506 | 9.902 | 10.928 |
| Accumulated Depreciation, Total | -5.568 | -6.386 | -6.724 | -6.749 |
| Goodwill, Net | 10.804 | 11.631 | 15.031 | 15.031 |
| Intangibles, Net | 16.852 | 15.092 | 13.26 | 11.617 |
| Other Long Term Assets, Total | 0.1 | 0.09 | 3.461 | 1.657 |
| Total Current Liabilities | 4.468 | 22.6 | 32.125 | 28.96 |
| Accounts Payable | 0.886 | 1.717 | 8.964 | 1.662 |
| Accrued Expenses | 1.568 | 1.899 | 4.69 | 4.899 |
| Notes Payable/Short Term Debt | 0 | 12.045 | 0 | 0 |
| Other Current Liabilities, Total | 2.014 | 6.939 | 6.631 | 22.38 |
| Total Liabilities | 53.125 | 76.213 | 79.904 | 56.37 |
| Total Long Term Debt | 23.099 | 23.812 | 15.926 | 9.993 |
| Long Term Debt | 23.099 | 23.812 | 15.926 | 9.993 |
| Other Liabilities, Total | 25.558 | 29.801 | 31.853 | 17.417 |
| Total Equity | -14.068 | -34.58 | 41.166 | 19.727 |
| Redeemable Preferred Stock | 183.962 | 193.959 | 0 | 0 |
| Common Stock | 0.001 | 0.001 | 0.027 | 0.031 |
| Additional Paid-In Capital | 2.107 | 2.324 | 299.953 | 321.669 |
| Retained Earnings (Accumulated Deficit) | -200.138 | -230.864 | -258.814 | -301.973 |
| Total Liabilities & Shareholders’ Equity | 39.057 | 41.633 | 121.07 | 76.097 |
| Total Common Shares Outstanding | 26.2541 | 26.2541 | 26.5615 | 30.7896 |
| Current Port. of LT Debt/Capital Leases | 0 | 11.84 | 0.019 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 81.244 | 68.45 | 56.445 | 43.613 | 27.233 |
| Denarna sredstva in kratkoročne naložbe | 55.329 | 56.349 | 47.913 | 32.712 | 16.427 |
| Denarna sredstva in ustrezniki | 55.329 | 56.349 | 47.913 | 32.712 | 16.427 |
| Celotne terjatve, neto | 18.367 | 5.281 | 2.784 | 3.656 | 3.774 |
| Accounts Receivable - Trade, Net | 18.367 | 5.281 | 2.784 | 3.656 | 3.774 |
| Other Current Assets, Total | 7.548 | 6.82 | 5.748 | 7.245 | 7.032 |
| Total Assets | 115.486 | 101.804 | 89.997 | 76.097 | 61.651 |
| Property/Plant/Equipment, Total - Net | 3.387 | 3.378 | 4.432 | 4.179 | 6.247 |
| Property/Plant/Equipment, Total - Gross | 10.369 | 10.471 | 11.827 | 10.928 | 13.409 |
| Accumulated Depreciation, Total | -6.982 | -7.093 | -7.395 | -6.749 | -7.162 |
| Goodwill, Net | 15.031 | 15.031 | 15.031 | 15.031 | 15.031 |
| Intangibles, Net | 12.821 | 12.4 | 11.992 | 11.617 | 11.131 |
| Other Long Term Assets, Total | 3.003 | 2.545 | 2.097 | 1.657 | 2.009 |
| Total Current Liabilities | 16.124 | 21.272 | 22.787 | 28.96 | 29.811 |
| Accounts Payable | 3.747 | 1.16 | 1.6 | 1.662 | 2.12 |
| Accrued Expenses | 2.622 | 2.959 | 3.533 | 4.899 | 4.597 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 2.707 | 3.106 | 0.02 | 0.019 | 0.051 |
| Other Current Liabilities, Total | 7.048 | 14.047 | 17.634 | 22.38 | 23.043 |
| Total Liabilities | 79.054 | 76.031 | 73.964 | 56.37 | 53.87 |
| Total Long Term Debt | 30.328 | 29.955 | 29.975 | 9.993 | 10.055 |
| Long Term Debt | 30.328 | 29.955 | 29.975 | 9.993 | 10.055 |
| Other Liabilities, Total | 32.602 | 24.804 | 21.202 | 17.417 | 14.004 |
| Total Equity | 36.432 | 25.773 | 16.033 | 19.727 | 7.781 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
| Common Stock | 0.027 | 0.027 | 0.027 | 0.031 | 0.032 |
| Additional Paid-In Capital | 302.18 | 302.923 | 304.697 | 321.669 | 325.308 |
| Retained Earnings (Accumulated Deficit) | -265.775 | -277.177 | -288.691 | -301.973 | -317.559 |
| Total Liabilities & Shareholders’ Equity | 115.486 | 101.804 | 89.997 | 76.097 | 61.651 |
| Total Common Shares Outstanding | 26.7854 | 26.9489 | 27.0201 | 30.7896 | 31.8893 |
- Letni
- Četrtletno
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -26.166 | -30.726 | -31.35 | -43.159 |
| Denarna sredstva iz poslovanja | -17.677 | -21.726 | -21.366 | -28.223 |
| Denarna sredstva iz poslovanja | 1.74 | 2.793 | 2.903 | 3.178 |
| Nedenarne postavke | 6.496 | 7.852 | 11.882 | 7.167 |
| Spremembe v obratnem kapitalu | 0.253 | -1.645 | -4.801 | 4.591 |
| Denarna sredstva pri naložbenju | -0.617 | -1.872 | -2.927 | -2.547 |
| Kapitalski izdatki | -0.617 | -1.416 | -2.177 | -2.547 |
| Celotne druge postavke denarnih tokov pri naložbenju | 0 | -0.456 | -0.75 | 0 |
| Denarna sredstva pri financiranju | 19.032 | 22.972 | 81.131 | 1.262 |
| Postavke denarnega toka pri financiranju | -0.283 | -0.119 | -8.249 | -0.5 |
| Izdaja (odplačilo) delnic, neto | 8.55 | 10.047 | 73.34 | 17.112 |
| Izdaja (odplačilo) dolga, neto | 10.765 | 13.044 | 16.04 | -15.35 |
| Neto sprememba denarnih sredstev | 0.738 | -0.626 | 56.838 | -29.508 |
| Denarna sredstva Plačane obresti | 1.844 | 1.676 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -6.961 | -18.363 | -29.877 | -43.159 | -15.586 |
| Cash From Operating Activities | -11.326 | -10.236 | -18.026 | -28.223 | -13.099 |
| Cash From Operating Activities | 0.746 | 1.523 | 2.323 | 3.178 | 0.908 |
| Non-Cash Items | 3.721 | 5.336 | 4.704 | 7.167 | 2.674 |
| Changes in Working Capital | -8.832 | 1.268 | 4.824 | 4.591 | -1.095 |
| Cash From Investing Activities | -0.516 | -0.864 | -1.906 | -2.547 | -0.352 |
| Capital Expenditures | -0.516 | -0.864 | -1.906 | -2.547 | -0.352 |
| Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
| Cash From Financing Activities | 4.951 | 5.229 | 5.625 | 1.262 | -2.834 |
| Financing Cash Flow Items | -0.108 | -0.109 | 0.232 | -0.5 | -4.6 |
| Issuance (Retirement) of Stock, Net | 0.475 | 0.679 | 0.739 | 17.112 | 1.674 |
| Issuance (Retirement) of Debt, Net | 4.584 | 4.659 | 4.654 | -15.35 | 0.092 |
| Net Change in Cash | -6.891 | -5.871 | -14.307 | -29.508 | -16.285 |
| Cash Interest Paid | 0.223 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| Schuler (Jack W) | Individual Investor | 27.8328 | 19952112 | 8695652 | 2022-11-21 | LOW |
| Kennedy (Lawrence T Jr.) | Individual Investor | 20.684 | 14827404 | 0 | 2023-01-03 | MED |
| Patience (John) | Individual Investor | 9.7923 | 7019695 | 1739130 | 2022-11-21 | LOW |
| Birchview Capital, LP | Investment Advisor | 7.0302 | 5039633 | 2884624 | 2022-12-31 | LOW |
| Cawthorn (Robert E) | Individual Investor | 5.0948 | 3652220 | 1723341 | 2022-11-21 | LOW |
| Strobeck (Matthew W) | Individual Investor | 4.052 | 2904668 | 1304345 | 2022-11-21 | LOW |
| Industrial Development Funding LLC | Corporation | 2.6454 | 1896374 | 0 | 2022-03-01 | LOW |
| Wells Fargo Advisors | Research Firm | 1.0724 | 768725 | 221413 | 2022-09-30 | LOW |
| Essex Investment Management Company, LLC | Investment Advisor/Hedge Fund | 0.5273 | 377994 | -29 | 2022-12-31 | LOW |
| Life Sciences Alternative Financing, L.L.C. | Corporation | 0.4102 | 294053 | 0 | 2022-03-01 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 0.3343 | 239656 | 59660 | 2022-09-30 | LOW |
| Cannell & Co. | Investment Advisor | 0.2868 | 205605 | 0 | 2022-12-31 | LOW |
| Hutton Scott | Individual Investor | 0.2389 | 171227 | 96218 | 2022-11-21 | LOW |
| Massarany (Hany) | Individual Investor | 0.1924 | 137934 | 130434 | 2022-11-21 | HIGH |
| Endurant Capital Management LP | Hedge Fund | 0.1815 | 130136 | -617 | 2022-09-30 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.1731 | 124070 | 27282 | 2022-09-30 | LOW |
| Millennium Management LLC | Hedge Fund | 0.1647 | 118048 | 728 | 2022-09-30 | HIGH |
| Bridgeway Capital Management, LLC | Investment Advisor | 0.1395 | 100000 | 50000 | 2022-09-30 | LOW |
| Pestano (Gary Anthony) | Individual Investor | 0.1294 | 92732 | 3474 | 2022-11-10 | |
| Cowie (Robin Harper) | Individual Investor | 0.1282 | 91920 | 25383 | 2022-11-21 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group +500000+
Borzni posredniki
93000+
Aktivne stranke mesečno
$57000000+
Mesečni obseg naložb
$31000000+
Preizkusi zdaj Dvigi vsak mesec
Kalkulator trgovanja
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trgovalna provizija
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Vzvod
20:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Biodesix, Inc. Company profile
O družbi Biodesix, Inc.
Biodesix, Inc. je podjetje s sedežem v Združenih državah Amerike, ki se ukvarja z razvojem in trženjem krvnih diagnostičnih testov za onkologijo. Njen izdelek Biodesix Lung Reflex združuje genomske in proteomske krvne rezultate, da bi razkril obe strani pljučnega raka. Njen test GeneStrat ponuja rezultate mutacij iz krvi v 72 urah za bolnike z nedrobnoceličnim pljučnim rakom (NSCLC). Njegovo testiranje VeriStrat zagotavlja napovedne in prognostične proteomske informacije iz krvi pri bolnikih z (NSCLC), pri katerih so testi za ocenjeno hitrost glomerulne filtracije (EGFR) negativni (EGFR wild-type) ali katerih status mutacije EGFR ni znan.
| Industry: | Medical & Diagnostic Laboratories |
Suite 100
2970 Wilderness Place
BOULDER
COLORADO 80301
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com